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Head  and  neck  cancer
Summary  Robots  have  invaded  industry  and,  more  recently,  the  ﬁeld  of  medicine.  Following
the development  of  various  prototypes,  Intuitive  Surgical® has  developed  the  Da  Vinci  surgical
robot. This  robot,  designed  for  abdominal  surgery,  has  been  widely  used  in  urology  since  2000.
The many  advantages  of  this  transoral  robotic  surgery  (TORS)  are  described  in  this  article.
Its disadvantages  are  essentially  its  high  cost  and  the  absence  of  tactile  feedback.  The  ﬁrst
feasibility studies  in  head  and  neck  cancer,  conducted  in  animals,  dummies  and  cadavres,  were
performed  in  2005,  followed  by  the  ﬁrst  publications  in  patients  in  2006.  The  ﬁrst  series  including
more than  20  patients  treated  by  TORS  demonstrated  the  feasibility  for  the  following  sites:
oropharynx,  supraglottic  larynx  and  hypopharynx.  However,  these  studies  did  not  validate  the
oncological  results  of  the  TORS  technique.  TORS  decreases  the  number  of  tracheotomies,  and
allows more  rapid  swallowing  rehabilitation  and  a  shorter  length  of  hospital  stay.  Technical
improvements  are  expected.  Smaller,  more  ergonomic,  new  generation  robots,  therefore  more
adapted to  the  head  and  neck,  will  probably  be  available  in  the  future.








ransoral  robotic  surgery  (TORS)  using  the  Da  Vinci  robot
arketed  by  Intuitive  Surgical® was  initially  developed  in
arious  surgical  specialties  (urology,  gynaecology,  cardiac
urgery,  etc.)  and  has  been  more  recently  introduced  for
he  treatment  of  head  and  neck  cancer.  More  than  twenty
tudies  have  been  published  since  2005  on  TORS  in  animals,
adavres  and  human  subjects  and  in  various  head  and  neck
ancer  sites  [1—7].
The  ﬁrst  two  parts  of  this  review  will  describe  the  devel-
pment  of  robotic  surgery  and  the  functioning  of  the  Da
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oi:10.1016/j.anorl.2011.06.003inci  robot,  respectively.  The  third  part  analyses  applica-
ion  of  the  Da  Vinci  robot  to  head  and  neck  cancer  and  the
reliminary  results  of  published  series.  TORS  is  designed  to
educe  postoperative  morbidity  and  improve  quality  of  life.
rospective  studies,  especially  in  France,  are  underway  to
valuate  the  oncological  results.
 brief history of robotic surgery
ollowing  their  creation  in  ﬁction,  robots  have  invaded  the
ndustrial  and  military  worlds.  The  word  ‘‘robot’’  was  used
or  the  ﬁrst  time  by  the  Czech  writer  Karel  Capek  in  a  sci-
nce  ﬁction  play  called  Rossum’s  Universal  Robots  (RUR).
apek  is  recognized  as  having  created  science  ﬁction  well





















aTransoral  robotic  surgery  in  head  and  neck  cancer  
author  imagined  a  future  in  which  all  workers  are  automats
that  only  revolt  once  they  have  acquired  a  soul  and  become
‘‘human’’.
After  being  developed  on  industrial  assembly  lines,
robots  such  as  drones  now  play  an  essential  role  in  war
zones.  In  the  medical  ﬁeld,  the  ﬁrst  robots  were  developed
in  rehabilitation  medicine  to  help  disabled  patients.  Robotic
surgery  was  initially  developed  in  the  ﬁeld  of  neurosurgery
because  of  the  rigid  structure  of  the  skull  providing  stable
anatomical  landmarks.  Stereotactic  surgery  has  been  exten-
sively  developed  since  the  beginning  of  the  1990s.  Otological
surgery  also  constitutes  a  ﬁeld  of  robotic  experimentation
especially  for  stapedectomy.
Robotic  surgery  was  ﬁrst  developed  by  the  American
armed  forces.  In  the  1980s,  in  order  to  perform  remote-
controlled  surgery  on  soldiers,  the  American  armed  forces,
in  partnership  with  Stanford  University,  California,  devel-
oped  a  research  programme  that  gave  birth,  in  particular,
to  a  start-up  called  Intuitive  Surgical  Inc.  During  the  1990s,
three  main  types  of  robots  were  developed:  Aesop  and  Zeus
by  Computer  Motion  Inc.  and  Da  Vinci  by  Intuitive  Surgical
Inc.  Intuitive  Surgical  Inc.  subsequently  acquired  Computer
Motion  and  currently  has  exclusive  worldwide  marketing
rights.
The  ﬁrst  surgical  operation  assisted  by  the  Da  Vinci
robot,  laparoscopic  splenectomy,  was  performed  in  1997.
This  procedure  was  followed  by  other  applications:  gas-
trectomy,  splenectomy,  oesophagectomy.  Clinical  studies
demonstrated  the  feasibility  of  using  a  robot  in  these  surgi-
cal  procedures,  but  with  no  real  beneﬁt  in  terms  of  operating
time,  length  of  hospital  stay,  quality  of  surgical  resection
and  quality  of  life  for  the  patient  compared  to  conventional
laparoscopic  surgery.  Various  disadvantages  were  reported:
the  cost  of  robotic  surgery  and  the  absence  of  tactile
feedback  preventing  tactile  control  by  the  surgeon.  The
advantages  were  excellent  vision  in  three  dimensions  and
manipulation  of  instruments  in  three  dimensions.  The  use  of
the  Da  Vinci  robot  was  approved  for  use  in  laparoscopy  by  the
Food  and  Drug  Administration  in  2000.  Robotic  surgery  was
progressively  developed  in  urology,  gynaecology,  and  tho-
racic  surgery.  Robotic  surgery  has  occupied  an  important
place  in  urology  since  the  ﬁrst  prostatectomy  performed
in  France  by  Professor  Abbou’s  team  at  Mondor  Univer-
sity  Hospital  in  2000  [8].  A  study  showed  that  robotic
surgery  allowed  a  more  favourable  postoperative  course
with  decreased  bleeding,  decreased  pain  and  a  shorter
length  of  hospital  stay.  Almost  65%  of  radical  prostatec-
tomies  in  the  United  States  are  now  performed  with  the  Da
Vinci  robot.
More  than  25  Da  Vinci® robots  have  been  purchased  by
public  or  private  hospitals  in  France  and  their  number  is  on
the  increase.
The Da Vinci robot
Use  of  a  robot  allows  the  surgeon  to  perform  more  complex
operations  than  would  be  possible  by  conventional  laparo-
scopic  surgery.  Robotic  surgery  has  several  advantages:
•  three-dimensional  vision  versus  two-dimensional  vision  in




tFigure  1  Surgeon  console.
 stable  vision,  as  the  camera  is  maintained  and  mobilized
by  one  of  the  articulated  arms  of  the  robot;
more  precise  and  ﬁner  instrument  control  with  greater
freedom  of  motion  in  all  three  dimensions;
suppression  of  physiological  tremor;
ﬁnally,  the  surgeon  is  seated  in  the  axis  of  the  console,
ensuring  more  favourable  ergonomic  conditions.
In  practice,  the  surgical  robot  is  used  to  control  endo-
copic  instruments  during  surgical  procedures.  The  robot
s  composed  of  three  elements:  a  surgeon  console  (Fig.  1)
ith  an  integrated  three-dimensional  stereoscopic  viewer,
 patient-side  cart  comprising  robotic  arms  (Fig.  2)  and  a
ision  system  (Fig.  3).  The  surgeon  is  seated  in  front  of
he  console  and  operates  instruments  by  means  of  the  two
aster  controls.  The  surgeon’s  head  rests  between  infrared
ensors  on  either  side  of  the  viewer  providing  a  magniﬁed
hree-dimensional  stereoscopic  view  of  the  operative  ﬁeld.
he  extremities  of  the  instruments  are  aligned  on  the  dis-
lay  screen  by  the  master  controls  to  ensure  natural  and
redictable  movements  of  the  instruments.
The  surgical  robot  allows  real-time  and  direct  control  of
nstrument  movements  by  the  surgeon.  It  uses  a  kinematic
ystem  (based  on  the  principles  of  articulated  movements)
llowing  the  surgeon  to  use  open  surgery  techniques  via  the
onsole.  These  open  surgical  techniques  are  instantaneously
onverted  into  minimally  invasive  surgical  techniques  at  the
urgical  ﬁeld.  The  robot  provides  the  surgeon  with  access
o  the  surgical  ﬁeld  via  small  incisions  without  compromis-
e34  
Figure  2  Patient-side  cart  with  robotic  arms.
Surgical  instruments  and  the  camera  are  ﬁtted  onto  robotic






























[laced  at  the  patient’s  head  as  a  safety  measure  and  to  aspirate
moke and  blood.
ng  dexterity,  precision  and  the  natural  movements  required
or  open  surgery.  The  electronic  components  of  the  robot
llow  scaled  reduction  of  movements  of  the  surgeon’s  hand,
educing  hand  movements  to  proportionally  smaller  move-
ents  of  the  extremity  of  the  instrument  in  the  surgical
igure  3  The  vision  system  allows  operating  room  personnel
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eld.  Robotic  instruments  have  a  total  of  six  degrees  of
reedom.  Various  adjustments  allow  the  surgeon  to  optimize
caled  reduction  according  to  various  clinical  applications.
hysiological  tremor  of  the  surgeon’s  hand  is  eliminated
y  an  electronic  ﬁltering  system  ensuring  stable  and  pre-
ictable  instrument  control.
However,  the  main  disadvantages  of  the  Da  Vinci  robot
re  its  cost  and  the  absence  of  tactile  feedback,  i.e.  the
urgeon  has  no  tactile  sensation  and  cannot  distinguish  a
exible  structure  from  a  ﬁrm  or  hard  structure.  However,
he  excellent  quality  of  vision  (×10)  compensates  for  the
bsence  of  tactile  feedback.  The  second  disadvantage  is
he  cost,  which  comprises  several  variables:  purchase  of  the
obot,  maintenance  and  the  purchase  of  speciﬁc  material  for
imited  use.
se of the Da Vinci robot in head and neck
ancer
efore  being  used  in  head  and  neck  cancer,  the  Stanford
eam  demonstrated  that  the  Da  Vinci  robot  could  be  used
n  animal  models  (pigs)  to  perform  resection  of  the  sub-
andibular  gland,  thyroid  gland  and  for  neck  dissections
9].  The  only  complication  was  postoperative  subcutaneous
mphysema.
Initially  developed  in  the  United  States  essentially  by  the
niversity  of  Pennsylvania  team  and  then  by  other  teams,
a  Vinci  robotic  surgery  has  been  shown  to  be  an  efﬁcient
ool  for  exposure  and  resection  of  tumors  situated  in  head
nd  neck  anatomical  sites  with  difﬁcult  endoscopic  access.
he  ﬁrst  studies  performed  in  animals,  dummies  and  human
adavres  were  published  in  2005  [1—4]. They  validated
pplication  of  robotic  surgery  to  the  head  and  neck  in  terms
f  feasibility  (sharing  of  the  airway  with  anaesthetists),
xposure,  haemostasis,  resection,  and  transoral  sutures.  For
xample,  the  University  of  Pennsylvania  team  showed  that
he  use  of  5  mm  instruments  compared  to  8  mm  instruments
llowed  improved  vision,  greater  ease  of  use  and  a  shorter
perating  time  [4].  Animal  models  were  also  used  to  perform
natomical  studies  for  skull  base  surgical  incisions  (ante-
ior  and  midline).  However,  the  transoral  route  could  not  be
sed  to  resect  the  following  regions:  nasopharynx,  clivus,
phenoid  and  the  pituitary  region  [10], but  provided  good
ccess  to  the  parapharyngeal  space  in  animals  [11]. In  human
adavres,  the  same  authors  demonstrated  the  feasibility  of
ccess  to  the  skull  base  by  a  combination  of  cervical  and
ransoral  routes  [10]. In  another  cadavre  study,  Hanna  et  al.
escribed  an  approach  to  the  skull  base  via  antrotomy  and
esection  of  the  posterior  part  of  the  nasal  septum  allowing
ontrol  of  the  cribriform  plate  of  the  ethmoid,  sella  turcica,
asopharynx  and  clivus  [12]. In  2008,  Ozer  and  Waltonen
roposed  an  incision  through  the  soft  palate  for  resection  of
asopharyngeal  lesions  [13].
Cadavre  studies  demonstrated  the  feasibility  of  robotic
urgery  in  various  anatomical  sites.  They  also  allowed  sur-
eons  to  acquire  the  various  skills  required  for  exposure,
esection  and  transoral  suture.  Several  Da  Vinci  robotic
urgery  training  courses  are  now  available  in  France  and
ther  countries.
These  experimental  studies  were  rapidly  followed  by
tudies  in  patients  with  head  and  neck  cancers  in  various
e35
Figure  4  Endotracheal  intubation  according  to  the  usual
modalities.  The  FK-retractor  allows  exposure  of  laryngeal  and

































dTransoral  robotic  surgery  in  head  and  neck  cancer  
sites,  essentially  the  oropharynx  and  larynx  [5—7]. These
studies  showed  that  the  three-arm  robot  was  perfectly
adapted  to  resection  of  head  and  neck  cancers.
The  ﬁrst  procedure  using  the  Da  Vinci  robot  in  man,
consisting  of  transoral  resection  of  a  vallecular  cyst,  was
published  in  2005  by  McLeod  and  Melder  [14]. Installation
of  the  robot  took  75  minutes  and  the  surgical  operation
lasted  30  minutes.  The  postoperative  course  was  unevent-
ful.  In  2006,  O’Malley  et  al.  reported  a  prospective  clinical
trial  evaluating  use  of  the  Da  Vinci  robot  in  three  patients
with  a  tumour  of  the  base  of  the  tongue  [6].  The  authors
stressed  the  value  of  the  FK  retractor  for  exposure  and  the
ease  of  use  of  the  instruments  ensuring  negative  surgical
margins  in  all  three  patients.  No  intraoperative  or  post-
operative  complications  were  observed.  In  2007,  the  same
team  published  the  preliminary  results  of  two  prospective
trials  of  supraglottic  laryngectomy  and  radical  tonsillectomy
[5,7].  Weinstein  et  al.  reported  the  results  observed  in  three
patients  with  supraglottic  laryngeal  cancer  treated  by  tran-
soral  robotic  surgery  using  the  Da  Vinci  robot  [7].  Solares
et  al.,  also  in  2007,  reported  a  series  of  three  patients,
in  whom  transoral  robotic  surgery  was  possible  for  only
one  patient  [15], with  inadequate  exposure  for  the  other
two  patients.  The  limitations  of  TORS  related  to  inadequate
transoral  exposure  were  also  emphasized  by  Rahbar  et  al.
in  a  series  of  ﬁve  children  with  laryngeal  cleft.  Adequate
exposure  could  not  be  achieved  in  three  patients.  No  post-
operative  complications  were  observed  in  the  two  children
operated  successfully  [16].
Two  recent  publications  reported  free  ﬂap  reconstruc-
tion  after  resection  of  head  and  neck  cancer.  Robotic  surgery
avoided  the  need  to  resect  the  mandible  [17,18].  Use  of  the
CO2 Laser  on  one  of  the  robotic  arms  has  been  described,
especially  for  supraglottic  laryngeal  tumours  [15,19]. The
contribution  of  an  imaging-guided  system  (resembling  neu-
ronavigation)  for  tumours  of  the  parapharyngeal  space  was
reported  by  a  New  York  team  [20].
In  practice,  in  head  and  neck  cancer,  the  surgical  robot
is  positioned  to  the  right  or  to  the  left  of  the  patient,  in  a
strictly  supine  position  on  the  operating  table.  The  axis  of
the  robot  is  at  an  angle  of  30◦ to  the  operating  table.  The
Da  Vinci® surgical  robot  protocol  used  in  our  centre  is  iden-
tical  to  that  described  by  Weinstein  et  al.  [5].  The  patient
is  intubated  according  to  usual  modalities  with  a  standard
endotracheal  tube  (Fig.  4).  The  ﬁrst  stage  of  the  operation
consists  of  exposure.  A  Mersuture® 0  or  1  (Ethicon®) suture  is
systematically  inserted  in  the  midline  of  the  mobile  tongue
to  retract  the  tongue  out  from  the  oral  cavity.  Exposure
of  the  lesion  requires  the  use  of  various  types  of  retrac-
tors.  Exposure  of  lesions  of  the  oral  cavity  requires  a  simple
mouth  gag  and  the  FK-Retractor® is  always  used  for  lesions
of  the  larynx  and  hypopharynx  (Fig.  4),  while  a  Boyle-Davis®
retractor  can  be  used  for  certain  oropharyngeal  tumours.
The  30◦ video-endoscope  is  always  used  to  visualize  the  lar-
ynx  and/or  hypopharynx,  and  we  also  generally  use  the  30◦
video-endoscope,  rather  than  the  0◦ video-endoscope,  for
the  oropharynx.  Like  other  authors  [5],  we  use  5  mm  instru-
ments.  For  all  TORS  procedures,  the  right  robotic  arm  is
equipped  with  5  mm  monopolar  electrocoagulation  and  the
left  robotic  arm  is  equipped  with  Maryland  dissector® for-
ceps;  the  camera  is  ﬁtted  on  the  central  arm  (Fig.  2).  Robotic




phen introduced  transorally.
orrect  positioning  of  the  robotic  arms  is  essential;  zones  of
east  constraint  must  be  located  allowing  free,  unobstructed
ovement  of  the  robotic  arms.  The  surgeon  operates  from
he  surgeon  console  according  to  the  modalities  of  robotic
urgery  (Fig.  1).  A  second  surgeon  is  systematically  placed
t  the  patient’s  head  to  aspirate  smoke,  blood  and  to  facil-
tate  exposure  of  certain  anatomical  structures  (Fig.  2).  A
lip  forceps  (Ethicon®)  is  always  prepared.  Patients  are  sys-
ematically  monitored  in  the  recovery  ward  for  the  ﬁrst
4  hours.
Following  the  pioneer  studies,  several  series  comprising
t  least  20  patients  treated  by  TORS  have  been  published.
einstein  et  al.  reported  a  prospective  study  based  on
 series  of  27  patients  treated  by  robotic  radical  tonsil-
ectomy  [5].  Surgical  margins  were  histologically  negative
n  25  patients.  The  following  postoperative  complications
ere  observed:  one  case  of  mucosal  haemorrhage,  one  tra-
heotomy  in  a  patient  with  sleep  apnoea  syndrome  and  two
ases  of  trismus.  Six  patients  required  prolonged  intuba-
ion  (mean:  2.7  days).  A  gastric  feeding  tube  was  used  in
ll  patients.  Adjuvant  radiotherapy  (possibly  combined  with
oncomitant  chemotherapy)  was  delivered  in  24  patients.
oore  et  al.  [21]  also  reported  the  preliminary  results
f  a  prospective  series  of  45  patients  with  cancer  of  the
ropharynx  (26  base  of  the  tongue,  19  lateral  wall  of  the
ropharynx).  Exposure  was  sufﬁcient  to  allow  TORS  in  every
ase.  Surgical  margins  were  negative  in  all  patients  and  no
ostoperative  complication  was  reported.  Fourteen  patients
equired  tracheotomy  (mean  duration:  7  days),  22  patients
ad  a  nasogastric  feeding  tube  (mean  duration:  12.5  days)
nd  eight  patients  had  a  gastric  feeding  tube  (mean  dura-
ion:  140.3  days).  The  mean  length  of  hospital  stay  was  3.8
ays.
Genden  et  al.  [22]  reported  their  preliminary  results
ased  on  a  series  of  20  patients  with  early-stage  cancer  of
arious  head  and  neck  sites  (oral  cavity,  oropharynx,  larynx
nd  hypopharynx).  Exposure  was  inadequate  in  two  patients,


































































































n  the  18  patients  treated  by  TORS.  No  tracheotomy  was
ecessary.  The  mean  robot  set-up  time  was  54.6  minutes
range:  20  to  140  minutes)  and  this  time  decreased  rapidly
ith  experience.
In  2009,  an  Australian  study  [23]  reported  a  series  of  62
atients,  including  eight  patients  with  inadequate  exposure.
umours  were  essentially  located  in  the  oropharynx  (61%  of
ases),  supraglottic  larynx  (22%  of  cases)  and  hypopharynx
5%).  Most  tumours  in  this  series  were  early-stage  tumours:
5%  of  T1  and  44%  of  T2.  Prolonged  intubation  for  more  than
8  hours  was  necessary  in  22%  of  patients  and  9%  required
ransient  tracheotomy.  Postoperative  complications  were  as
ollows:  laryngeal  oedema  in  9%  of  patients,  aspiration  in  6%,
leeding  in  6%  and  salivary  leakage  in  2%.  Oral  feeding  was
estored  within  the  ﬁrst  two  weeks  for  83%  of  patients,  but
7%  of  patients  had  a  feeding  tube  at  1  year.  Neoadjuvant
r  adjuvant  radiotherapy  was  delivered  in  22%  and  41%  of
atients,  respectively.
In  2010,  a  South  Korean  team  [24]  reported  the  results  of
 series  of  ten  patients  with  cancer  of  the  pyriform  sinus
nd/or  posterior  pharyngeal  wall.  Exposure  using  the  FK
etractor  allowed  TORS  in  all  patients.  The  mean  operating
ime  was  62.4  minutes  and  the  mean  robot  set-up  time  was
7.5  minutes.  Tracheotomy  was  performed  in  all  patients
mean  decannulation  time:  6.3  days).  Oral  feeding  was
esumed  after  an  average  of  8.3  days  and  no  complications
ere  observed.
The  preliminary  results  of  these  ﬁrst  published  series
re  not  sufﬁcient  to  validate  the  oncological  results  of  this
echnique.  However,  they  clearly  demonstrate  the  feasi-
ility  of  this  procedure  in  the  following  sites:  lateral  wall
f  the  oropharynx,  base  of  the  tongue,  supraglottic  lar-
nx,  hypopharynx.  These  studies  show  that  the  essential
ontraindications  of  TORS  in  head  and  neck  cancer  are  con-
raindications  to  general  anaesthesia,  inadequate  exposure
r  unresectable  tumour  due  to  the  site  and/or  size  of  the
umour.  Mandibular  bone  invasion,  advanced  tumours  of  the
ase  of  the  tongue  requiring  resection  of  more  than  50%
f  the  tongue,  advanced  tumours  of  the  pharynx  requir-
ng  resection  of  more  than  50%  of  the  posterior  wall  and
ertebral  involvement  currently  appear  to  be  oncological
ontraindications  to  tumour  resection  by  robotic  surgery:
hese  situations  also  constitute  contraindications  for  conser-
ative  pharyngolaryngeal  and  oropharyngeal  surgery.  Most
mportantly,  TORS  decreases  the  tracheotomy  rate,  allows
ore  rapid  swallowing  rehabilitation  and  a  shorter  length
f  hospital  stay.  TORS  should  provide  a  better  quality  of  life
han  open  surgery  or  chemoradiotherapy.
The  main  disadvantage  of  robotic  surgery  is  its  cost:  pur-
hase  of  the  surgical  robot,  high  maintenance  costs  and
urchase  of  instruments  for  limited  use.  These  costs  are
ot  covered  by  T2A  (casemix-based  payment  system)  and
re  not  listed  in  the  Common  Classiﬁcation  of  Medical  Pro-
edures  (CCAM).  Intuitive  Surgical  Inc.  is  the  only  company
urrently  marketing  surgical  robots.
Use  of  the  robot  is  fairly  simple,  but  requires  a  training
eriod  and  a  learning  curve.  Close  collaboration  with  anaes-
hetists  is  essential,  especially  to  manage  sharing  of  the
irway.  Operating  room  nurses  must  be  trained  in  the  speci-
cities  of  this  surgery  and  must  be  prepared  for  conversion
o  open  surgery.  Pathologists  must  adapt  their  practice  toS.  Hans  et  al.
xamine  different  types  of  operative  specimens  from  those
btained  by  open  surgery.
Robotic  surgery  guidelines  in  gastrointestinal  surgery
ere  published  in  2006  [25]. Technical  improvements  are
xpected.  A  ﬁbre  laser  on  one  of  the  robotic  arms  should
e  released  onto  the  market  in  the  near  future.  Smaller  and
ore  ergonomic  new  generation  robots  will  also  probably
ecome  available.  Intuitive  Surgical® robots  were  developed
or  gastrointestinal  surgery,  urology,  or  gynaecology,  but  the
ize  of  the  robotic  arms  and  instruments  are  not  adapted
o  otological,  transnasal  and  transoral  surgery.  Research  is
urrently  underway  at  the  Johns  Hopkins  University  on  a
ew  prototype  ‘‘Snakebot’’  robot  equipped  with  smaller
nd  ﬂexible  instruments.  Instruments  with  eight  degrees  of
reedoms  would  allow  snake-like  movements  [26].
In  France,  since  2008,  about  ten  centres  have  been  devel-
ping  TORS  and  have  formed  a  transoral  robotic  surgery
roup  [27,28].
onclusion
obotic  surgery  allows  transformation  of  open  surgical  man-
gement  of  head  and  neck  cancer  to  transoral  minimally
nvasive  surgery.
The  advantages  of  robotic  surgery  in  patients  with  head
nd  neck  cancer  are  access  to  anatomical  sites  not  accessi-
le  to  conventional  endoscopy,  absence  of  a neck  incision,
bsence  or  decreased  duration  of  tracheotomy,  absence  or
ecreased  duration  of  nasogastric  or  gastric  feeding  tube
nd  decreased  length  of  hospital  stay.
The  electronic  interface  of  the  vision  and  instrument
ystem  gives  a  new  dimension  to  telesurgery,  allowing  the
atient  to  be  operated  at  a distance  by  a  specialist  surgeon
rom  anywhere  in  the  world.
In  view  of  the  growing  number  of  surgical  robots  now
vailable  in  public  and  private  hospitals  and  the  pres-
ure  exerted  by  patients  and  patient  associations  to  have
ccess  to  minimally  invasive  surgery,  the  following  aspects
f  robotic  surgery  need  to  be  studied:  indications  and  onco-
ogical  results  in  patients  treated  by  TORS,  advantages  of
obotic  minimally  invasive  surgery  compared  to  open  surgery
r  concomitant  chemoradiotherapy  in  terms  of  morbidity
nd  decreased  length  of  hospital  stay,  together  with  quality
f  life  and  medico-economic  evaluation.
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